JP2010500343A5 - - Google Patents

Download PDF

Info

Publication number
JP2010500343A5
JP2010500343A5 JP2009523744A JP2009523744A JP2010500343A5 JP 2010500343 A5 JP2010500343 A5 JP 2010500343A5 JP 2009523744 A JP2009523744 A JP 2009523744A JP 2009523744 A JP2009523744 A JP 2009523744A JP 2010500343 A5 JP2010500343 A5 JP 2010500343A5
Authority
JP
Japan
Prior art keywords
formula
compound
base
iii
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009523744A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010500343A (ja
Filing date
Publication date
Priority claimed from GBGB0615619.4A external-priority patent/GB0615619D0/en
Application filed filed Critical
Publication of JP2010500343A publication Critical patent/JP2010500343A/ja
Publication of JP2010500343A5 publication Critical patent/JP2010500343A5/ja
Pending legal-status Critical Current

Links

JP2009523744A 2006-08-05 2007-08-02 芳香族シクロプロパンエステル及びアミドの化学的製造法 Pending JP2010500343A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0615619.4A GB0615619D0 (en) 2006-08-05 2006-08-05 Chemical process for preparation of intermediates
PCT/SE2007/000706 WO2008018822A1 (en) 2006-08-05 2007-08-02 Chemical process for preparation of aromatic cyclopropane esters and amides

Publications (2)

Publication Number Publication Date
JP2010500343A JP2010500343A (ja) 2010-01-07
JP2010500343A5 true JP2010500343A5 (US20040106767A1-20040603-C00005.png) 2010-09-16

Family

ID=37027327

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009523744A Pending JP2010500343A (ja) 2006-08-05 2007-08-02 芳香族シクロプロパンエステル及びアミドの化学的製造法

Country Status (16)

Country Link
US (2) US7863469B2 (US20040106767A1-20040603-C00005.png)
EP (1) EP2049462A4 (US20040106767A1-20040603-C00005.png)
JP (1) JP2010500343A (US20040106767A1-20040603-C00005.png)
KR (1) KR20090045920A (US20040106767A1-20040603-C00005.png)
CN (1) CN101495442A (US20040106767A1-20040603-C00005.png)
AR (1) AR062148A1 (US20040106767A1-20040603-C00005.png)
AU (1) AU2007282181B2 (US20040106767A1-20040603-C00005.png)
BR (1) BRPI0714573A2 (US20040106767A1-20040603-C00005.png)
CA (1) CA2658953A1 (US20040106767A1-20040603-C00005.png)
CL (1) CL2007002267A1 (US20040106767A1-20040603-C00005.png)
GB (1) GB0615619D0 (US20040106767A1-20040603-C00005.png)
IL (1) IL196233A0 (US20040106767A1-20040603-C00005.png)
MX (1) MX2009001020A (US20040106767A1-20040603-C00005.png)
MY (1) MY147871A (US20040106767A1-20040603-C00005.png)
TW (1) TW200812958A (US20040106767A1-20040603-C00005.png)
WO (1) WO2008018822A1 (US20040106767A1-20040603-C00005.png)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0615620D0 (en) 2006-08-05 2006-09-13 Astrazeneca Ab A process for the preparation of optically active intermediates
GB0615619D0 (en) * 2006-08-05 2006-09-13 Astrazeneca Ab Chemical process for preparation of intermediates
US8563755B2 (en) 2008-09-09 2013-10-22 Astrazeneca Ab Process for preparing [1S-[1-α, 2-α, 3-β(1S*,2R*) 5-β]]-3-[7-[2-(3,4-difluorophenyl)-cyclopropylamino]-5-(propylthio)-3H-1,2,3-triazolo [4,5-d] pyrimidin-3-yl]-5-(2-hydroxyethoxy) cyclopentane-1,2-diol and to its intermediates
SI2389372T1 (sl) * 2009-01-23 2016-02-29 Rigel Pharmaceuticals, Inc. Sestavki in postopki za inhibicijo poti JAK
US20130150577A1 (en) 2010-04-20 2013-06-13 Actavis Group Ptc Ehf Novel process for preparing phenylcyclopropylamine derivatives using novel intermediates
CN103003231A (zh) * 2010-06-30 2013-03-27 阿特维斯集团公司 制备苯基环丙基胺衍生物的新方法及其用于制备替卡格雷的用途
WO2012063126A2 (en) 2010-11-09 2012-05-18 Actavis Group Ptc Ehf Improved processes for preparing pure (3ar,4s,6r,6as)-6-amino-2,2-dimethyltetrahdro-3ah-cyclopenta[d] [1,3]-dioxol-4-ol and its key starting material
RU2013133879A (ru) 2010-12-20 2015-01-27 Актавис Груп Птс Ехф НОВЫЕ СПОСОБЫ ПОЛУЧЕНИЯ ТРИАЗОЛО[4, 5-d]ПИРИМИДИНА, ЕГО ПРОИЗВОДНЫЕ И ПРОМЕЖУТОЧНЫЕ СОЕДИНЕНИЯ
CA2839057A1 (en) 2011-06-15 2012-12-20 Actavis Group Ptc Ehf Improved process for preparing cyclopentylamine derivatives and intermediates thereof
EP2589587A1 (en) 2011-11-04 2013-05-08 Chemo Ibérica, S.A. Synthesis of nitrogen substituted cyclopropanes
EP2628721A1 (en) 2012-02-20 2013-08-21 LEK Pharmaceuticals d.d. Synthesis of 2-(3,4-difluorophenyl)cyclopropanecarboxylic acid
CN104603098B (zh) 2012-03-30 2016-06-29 桑多斯股份公司 2-(3,4-二氟苯基)环丙胺衍生物和盐的合成
EP2644590A1 (en) 2012-03-30 2013-10-02 LEK Pharmaceuticals d.d. Synthesis of 2-(3,4-difluorophenyl)cyclopropanamine derivatives and salts
EP2834247A4 (en) 2012-04-05 2016-03-30 Reddys Lab Ltd Dr PREPARATION OF TICAGRELOR
CN102775314A (zh) * 2012-08-03 2012-11-14 江苏富泽药业有限公司 一种反式-(1r,2s)-2-(3,4-二氟苯基)环丙胺的制备方法
CN103664697B (zh) * 2012-09-07 2016-12-21 博瑞生物医药(苏州)股份有限公司 用于制备芳香族环丙腈及环丙胺的化学方法
CN102863341B (zh) * 2012-10-22 2014-05-07 南通大学 一种(1r,2s)-2-芳基环丙胺衍生物的化学合成方法
CN103087011A (zh) * 2013-02-04 2013-05-08 北京科技大学 一种水解动力学拆分制备(s)-3,4-二氟苯基环氧乙烷的方法
CN103073525B (zh) * 2013-02-04 2015-01-28 北京科技大学 一种合成制备(s)-(3,4-二氟苯基)环氧己烷的方法
WO2014206187A1 (zh) 2013-06-24 2014-12-31 苏州明锐医药科技有限公司 替卡格雷及其中间体的制备方法
CN104974017B (zh) * 2014-04-09 2017-11-17 上海医药工业研究院 (1r,2s)‑2‑(3,4‑二氟苯基)环丙胺·d‑扁桃酸盐的制备方法
WO2015162630A1 (en) 2014-04-25 2015-10-29 Anlon Chemical Research Organization Novel processes for preparing triazolo [4,5-d]- pyrimidines, including ticagrelor, vianew intermediates and new route of synthesis.
JP6499672B2 (ja) 2014-05-15 2019-04-10 アレイ バイオファーマ、インコーポレイテッド TrkAキナーゼ阻害剤としての1−((3S,4R)−4−(3−フルオロフェニル)−1−(2−メトキシエチル)ピロリジン−3−イル)−3−(4−メチル−3−(2−メチルピリミジン−5−イル)−1−フェニル−1H−ピラゾール−5−イル)尿素
EP3157907B1 (en) 2014-06-18 2018-08-29 Flamma S.P.A. Process for the preparation of triazolo[4,5-d]pyrimidine cyclopentane compounds
CN104326922B (zh) * 2014-11-03 2016-08-17 成都百裕制药股份有限公司 替格瑞洛中间体(1r,2s)-2-(2,3-二氟苯基)环丙胺的制备方法
TWI579259B (zh) * 2014-12-17 2017-04-21 日名國際藥品有限公司 製備(1r,2s)-2-(3,4-二氟苯基)-3-r取代-環丙胺的方法
WO2016116942A1 (en) 2015-01-20 2016-07-28 Anlon Chemical Research Organization Novel pharmaceutical compounds comprising ticagrelor with salts of aspirin
CN105671099A (zh) * 2016-01-26 2016-06-15 中国科学院成都生物研究所 一种制备光学纯二氟苯基环氧乙烷的方法
CN106854158B (zh) * 2016-12-08 2019-06-14 淮阴工学院 一种替格瑞洛中间体的合成方法及其中间体
CN106905182A (zh) * 2017-01-12 2017-06-30 淮阴工学院 一种替格瑞洛中间体的合成方法及其中间体
CN107118141B (zh) * 2017-04-18 2018-11-30 淮阴工学院 一种替格瑞洛中间体的合成方法及其中间体
CN107686447A (zh) * 2017-08-25 2018-02-13 许昌恒生制药有限公司 一种替格瑞洛中间体的制备方法
CN108083997A (zh) * 2017-11-14 2018-05-29 南通常佑药业科技有限公司 一种手性芳基环丙胺衍生物的制备方法
EP3617181A1 (en) 2018-08-30 2020-03-04 Arevipharma GmbH Synthesis of trans-2-phenylcyclopropylamine or a salt or solvate thereof
CN110437092B (zh) * 2019-07-11 2022-06-10 泓博智源(开原)药业有限公司 一种替格瑞洛关键中间体芳族环丙烷酰胺的制备方法
CN111233673B (zh) * 2020-02-26 2022-08-16 苏州元兴生物医药有限公司 一种手性芳香族环丙胺及其盐的制备方法及所用中间体
CN115894496A (zh) * 2021-09-30 2023-04-04 上海贝美医药科技有限公司 一种替格瑞洛及其中间体的制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4411925A (en) * 1980-01-21 1983-10-25 Pfizer Inc. Branched amides of L-aspartyl-d-amino acid dipeptides
US4590292A (en) * 1985-06-10 1986-05-20 Ciba-Geigy Corporation Process for the manufacture of cyclopropylamine
DE3546372A1 (de) * 1985-12-31 1987-07-02 Basf Ag Neue phenylacetaldehyde und verfahren zur herstellung von phenylacetaldehyden
DE3729226A1 (de) * 1987-09-02 1989-03-23 Basf Ag Verfahren zur herstellung von phenylsubstituierten epoxiden
DE3909142A1 (de) 1989-03-21 1990-10-04 Basf Ag Verfahren zur herstellung von aminen
EP0611826B1 (en) * 1993-02-15 2003-05-02 Daicel Chemical Industries, Ltd. Processes for production of optically active epoxides
DE4315623A1 (de) 1993-05-11 1994-11-17 Hoechst Ag Verfahren zur Herstellung von Aminen
DE4400328A1 (de) * 1994-01-07 1995-07-13 Huels Chemische Werke Ag Verfahren zur Herstellung von Cyclopropancarbonsäureamid
DE19523868A1 (de) 1995-06-30 1997-01-02 Huels Chemische Werke Ag Verfahren zur Herstellung von Cyclopropanamin
DE19547635A1 (de) * 1995-12-20 1997-06-26 Bayer Ag Verfahren zur Herstellung von Cyclopropancarbonsäureamiden
TWI290549B (en) * 2000-06-02 2007-12-01 Astrazeneca Ab Process for the preparation of cyclopropyl carboxylic acid ester and derivatives
GB0013488D0 (en) * 2000-06-02 2000-07-26 Astrazeneca Ab Chemical compound
US6552217B2 (en) * 2000-08-01 2003-04-22 Eastman Chemical Company Process for the preparation of alkyl 1-methylcyclopropanecarboxylate
US6683216B1 (en) * 2002-11-06 2004-01-27 Eastman Chemical Company Continuous process for the preparation of amines
GB0615620D0 (en) * 2006-08-05 2006-09-13 Astrazeneca Ab A process for the preparation of optically active intermediates
GB0615619D0 (en) * 2006-08-05 2006-09-13 Astrazeneca Ab Chemical process for preparation of intermediates

Similar Documents

Publication Publication Date Title
JP2010500343A5 (US20040106767A1-20040603-C00005.png)
JP2009542613A5 (US20040106767A1-20040603-C00005.png)
JP2009143956A5 (US20040106767A1-20040603-C00005.png)
JP2015501820A5 (US20040106767A1-20040603-C00005.png)
NZ593712A (en) Intermediates for synthesising nucleoside aryl phosphoramidates
JP2013032389A5 (US20040106767A1-20040603-C00005.png)
JP2011523952A5 (US20040106767A1-20040603-C00005.png)
JP2008255122A5 (US20040106767A1-20040603-C00005.png)
JP2010043124A5 (US20040106767A1-20040603-C00005.png)
JP2010138190A5 (US20040106767A1-20040603-C00005.png)
JP2014508811A5 (US20040106767A1-20040603-C00005.png)
JP2013542261A5 (US20040106767A1-20040603-C00005.png)
JP2013505929A5 (US20040106767A1-20040603-C00005.png)
JP2010534247A5 (US20040106767A1-20040603-C00005.png)
JP2013537905A5 (US20040106767A1-20040603-C00005.png)
JP2010530373A5 (US20040106767A1-20040603-C00005.png)
JP2012092103A5 (US20040106767A1-20040603-C00005.png)
JP2014521688A5 (US20040106767A1-20040603-C00005.png)
JP2007302689A5 (US20040106767A1-20040603-C00005.png)
JP2014500861A5 (US20040106767A1-20040603-C00005.png)
JP2011524871A5 (US20040106767A1-20040603-C00005.png)
JP2010519270A5 (US20040106767A1-20040603-C00005.png)
JP2011088926A5 (US20040106767A1-20040603-C00005.png)
JP2010529994A5 (US20040106767A1-20040603-C00005.png)
JP2008542386A5 (US20040106767A1-20040603-C00005.png)